Literature DB >> 1315861

Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids.

R D Spealman1, J Bergman.   

Abstract

The effects of cocaine alone and after pretreatment with selective mu and kappa opioids were determined in squirrel monkeys trained to discriminate i.m. injections of cocaine from vehicle in a two-lever discrimination procedure. Lever pressing was maintained under a fixed ratio schedule of food presentation. When administered alone, cocaine engendered dose-related increases in the proportion of cocaine-appropriate responding with an average ED50 of 0.19 mg/kg. Pretreatment with the mu agonists morphine (0.3 and 1.0 mg/kg), levorphanol (0.03 and 0.1 mg/kg) and methadone (0.1 and 0.3 mg/kg), as well as the mu partial agonist buprenorphine (3.0 and 5.6 micrograms/kg), potentiated the discriminative stimulus effects of cocaine such that the cocaine dose-effect functions were shifted to the left and the average ED50 for cocaine was reduced maximally by about one order of magnitude. None of the mu agonists consistently substituted for cocaine when administered alone, indicating that the observed interactions were not simply the result of additive discriminative stimulus effects. A similar potentiation by mu agonists was observed for the effects of cocaine on fixed ratio response rate. In contrast to the mu agonists, pretreatment with the kappa agonists N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4,5]dec-8-yll-4- benzofuranacetamide (CI 977; 3.0 and 5.6 micrograms/kg) and benzeneacetamide methane sulfonate (U 50,488; 0.3 and 1.0 mg/kg) attenuated the discriminative stimulus effects of cocaine in most monkeys, resulting in a modest (2- to 3-fold) increase in the average ED50 for cocaine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315861

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.

Authors:  Mark A Smith; Keith A Gordon; Christopher K Craig; Paul A Bryant; M Eric Ferguson; Adam M French; Jason D Gray; Jacob M McClean; Jonathan C Tetirick
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

2.  Role of Long Noncoding RNA Gas5 in Cocaine Action.

Authors:  Haiyang Xu; Amber N Brown; Nicholas J Waddell; Xiaochuan Liu; Graham J Kaplan; Javed M Chitaman; Victoria Stockman; Rachel L Hedinger; Ryan Adams; Kristen Abreu; Li Shen; Rachael Neve; Zuoxin Wang; Eric J Nestler; Jian Feng
Journal:  Biol Psychiatry       Date:  2020-05-11       Impact factor: 13.382

3.  Limbic activation during cue-induced cocaine craving.

Authors:  A R Childress; P D Mozley; W McElgin; J Fitzgerald; M Reivich; C P O'Brien
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

4.  Enhancement of cocaine's abuse liability in methadone maintenance patients.

Authors:  K L Preston; J T Sullivan; E C Strain; G E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

5.  Discriminative stimulus effects of the 5HT1A agonist 8-OH-DPAT: attenuation by mu but not by kappa opioids.

Authors:  D Morgan; M J Picker
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 6.  Cyclazocine revisited.

Authors:  S Archer; S D Glick; J M Bidlack
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

7.  Neuropharmacological characterization of local ibogaine effects on dopamine release.

Authors:  M S Reid; K Hsu; K H Souza; P A Broderick; S P Berger
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle.

Authors:  Robert E Vann; Laura E Wise; Stephen A Varvel; Scott D Philibin; D Matthew Walentiny; Joseph H Porter
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

9.  U-69593, a kappa opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats.

Authors:  Anabel Puig-Ramos; Gladys S Santiago; Annabell C Segarra
Journal:  Behav Neurosci       Date:  2008-02       Impact factor: 1.912

10.  Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys.

Authors:  S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.